Series B

DEER PARK, Ill., August 5, 2026 Eton Pharmaceuticals has licensed the U.S. rights to ASN-001 (timolol topical gel) from...

Glasgow, Scotland, August 5, 2026 Mironid has successfully raised $46 million in a Series B financing round to accelerate...

BOSTON, Mass., July 7, 2026 Handspring Health has secured $19 million in Series B financing, with Angelini Ventures participating...

BOULDER, Colo., USA — March 31, 2026 Ambrosia Biosciences Inc. has announced the successful completion of a $100 million...

London, United Kingdom | January 29, 2026 — LifeArc Ventures, the venture capital arm of medical research organization LifeArc,...

BRISBANE, CA – November 13, 2025 — Gate Bioscience announced the closing of an oversubscribed $65 million Series B...